Quick Answer
ProMIS Neurosciences Inc. reported Stockholders Equity of -$1.26 million for fiscal year 2025.
ProMIS Neurosciences Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$1.26M | -107.6% |
| 2024 | $16.49M | +339.3% |
| 2023 | $3.75M | +378.5% |
| 2022 | -$1.35M | -123.8% |
| 2021 | $5.66M | +810.5% |
| 2020 | -$796.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $9.19M | +26.3% | +2501.4% |
| June 30, 2025 | -$382.6K | +83.2% | -104.0% |
| March 31, 2025 | $9.47M | +12185.2% | -42.6% |
| December 31, 2024 | $16.49M | +339.3% | +126.7% |
| September 30, 2024 | $7.27M | +7.7% | +419.4% |
| June 30, 2024 | -$2.28M | +73.3% | -3053.4% |
| March 31, 2024 | $77.1K | +101.2% | -97.9% |
| December 31, 2023 | $3.75M | +378.5% | -44.4% |
- ProMIS Neurosciences Inc. showed a decrease of -107.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, ProMIS Neurosciences Inc.’s stockholders equity has declined by 58.0% (from -$796.7 thousand to -$1.26 million).
- The most recent figure is from ProMIS Neurosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: